SEC Form D · filed September 27, 2013
ACCELERON PHARMA INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Steven L. Ertel · CAMBRIDGE, MAExecMatthew L. Sherman · CAMBRIDGE, MAExecJean M. George · CAMBRIDGE, MADirectorKevin F. Mclaughlin · CAMBRIDGE, MAExecTerrance G. Mcguire · CAMBRIDGE, MADirectorAnthony B. Evnin · CAMBRIDGE, MADirectorGeorge S. Golumbeski · CAMBRIDGE, MADirectorRobert L. Steininger · CAMBRIDGE, MAExecTom W. Maniatis · CAMBRIDGE, MADirectorJohn Knopf · CAMBRIDGE, MAExec · DirectorJoseph S. Zakrzewski · CAMBRIDGE, MADirectorRichard F. Pops · CAMBRIDGE, MADirectorEdwin M. Kania, Jr · CAMBRIDGE, MADirectorErik Pampalone · Chatsworth, CAExec · DirectorDavid Turnerr · San Diego, CAExecJohn Montieth · San Diego, CADirectorJeffrey Closs · Palo Alto, CADirectorGuido Neels · Palo Alto, CADirectorThomas A. Proulx · San Francisco, CADirectorSteven B. Jaffee · Indianapolis, INExecRobert Segal · TORONTO, Ontario, CanadaExecWilliam Holland · TORONTO, Ontario, CanadaExecWilliam Fielding · TORONTO, Ontario, CanadaDirectorWilliam Levy · TORONTO, Ontario, CanadaDirectorHarp Gahunia · TORONTO, Ontario, CanadaDirectorEdwin M. Kania, Jr · Needham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗